课题基金 / 基金详情

项目摘要

项目成果

YUSUKE MARIKAWA的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):卵母细胞的冷冻保存对于女性的生育能力的保存正变得至关重要。由于化疗和放射治疗等癌症治疗而即将丧失卵巢功能的癌症患者,可以保存他们未受损的卵母细胞,供以后使用。由于职业或婚姻状况而希望在较大年龄生育的女性可以通过使用保存下来的年轻卵母细胞来实现这一目标,这些卵母细胞很可能具有完整的染色体。在过去的几年里,许多婴儿是从冷冻保存的卵母细胞中出生的。尽管如此,卵母细胞冷冻仍然被认为是一种实验程序,不同临床的成功率是不同的。因此,玻璃化冷冻过程需要进一步研究其安全性和稳健性,在细胞和分子水平上仔细检查。这种方法对于预测对卵母细胞的任何潜在损害尤其关键,因为这种损害可能会影响卵母细胞发育成健康的个体。这项建议的重点是在玻璃化冷冻过程中的减数分裂纺锤体再生的机制,这是利用快速冷冻法冷冻保存卵母细胞。减数分裂纺锤体是将正确数目的染色体分离到卵母细胞中的关键器官。纺锤体的损伤可能会导致染色体不分离,这是导致发育障碍和出生缺陷的主要原因。众所周知,减数分裂纺锤体在卵母细胞冷冻过程中退化,但在解冻和加温过程中再生。然而,纺锤体是如何再生的,没有纺锤体的染色体配对是否稳定,还没有得到充分的研究。在这方面,我正在追求以下三个具体目标,使用老鼠和人类的卵母细胞。在具体目标1中,将在玻璃化过程中检查几种纺锤体成核成分,如g-微管蛋白、周丝蛋白和NEDD1的定位。我的假设是,这些成核成分在卵母细胞冷冻过程中不会受到干扰,因此它们可以作为解冻后纺锤体再生的组织中心。在具体目标2中,我将实时监测主轴再生的动态过程。再生过程将通过使用表达绿色荧光蛋白标记的b-微管蛋白的活卵母细胞的荧光延时电影照相术来检测。这一分析将在空间和时间上洞察纺锤体再生的模式。在具体目标3中,将研究中期染色体在没有纺锤体的情况下的稳定性。由于卵母细胞玻璃化冷冻导致减数分裂纺锤体解聚,它可能会破坏染色体排列的稳定性,增加不分离的机会。我将确定各种玻璃化条件,特别是最初的平衡步骤,对中期平板上染色体排列的影响。这些信息将帮助我们改进玻璃化冷冻方案,以建立更一致和更安全的卵母细胞冷冻保存。
英文摘要
DESCRIPTION (provided by applicant): Cryopreservation of oocytes is becoming crucial for fertility preservation in women. Cancer patients who are about to lose their ovarian function because of cancer treatments, like chemotherapy and radiotherapy, can preserve their undamaged oocytes for later use. Women who desire to have a child at older ages due to their career or marital status can do so by using their preserved young oocytes that are likely to have intact chromosomes. In the past several years, a number of babies were born that were derived from cryopreserved oocytes. Nonetheless, oocyte cryopreservation is still considered as an experimental procedure, and success rates are variable among clinics. Thus, the process of vitrification needs to be further investigated for its safety and robustness by examining it carefully at the cellular and molecular levels. Such approaches are particularly critical to predict any potential damage to oocytes, which may affect their development into healthy individuals. The focus of this proposal is on the mechanisms of meiotic spindle regeneration during vitrification, which utilizes the fast-freezing method to cryopreserve oocytes. The meiotic spindle is a crucial apparatus to segregate the correct number of chromosomes into an oocyte. Damages to the spindle potentially result in chromosome nondisjunction, which is a major cause of developmental failure and birth defects. It is known that meiotic spindle degenerates during oocyte freezing but it regenerates during thawing and warming. However, how the spindle regenerates and whether chromosome alignment is stable without the spindle have not been fully investigated. In that respect, I am pursuing the following three Specific Aims, using the mouse as well as human oocytes. In Specific Aim 1, the localization of several spindle-nucleating components, such as g-tubulin, pericentrin, and NEDD1, will be examined during the vitrification process. My hypothesis is that these nucleating components are undisturbed during oocyte freezing so that they can serve as the organizing center for spindle regeneration after thawing. In Specific Aim 2, I will monitor the dynamic process of spindle regeneration in real time. The regeneration process will be examined by fluorescence time-lapse cinematography using live oocytes that express Green Fluorescent Protein-tagged b-tubulin. This analysis will generate insight into the mode of spindle regeneration in a spatial and temporal manner. In Specific Aim 3, the stability of metaphase chromosomes in the absence of spindle will be investigated. Because oocyte vitrification causes depolymerization of the meiotic spindle, it may destabilize alignment of chromosomes and increase the chance of nondisjunction. I will determine the effect of various vitrification conditions, particularly of the initial equilibration step, on chromosome alignment at the metaphase plate. This information will help us improve the vitrification protocol to establish a more consistent and safer cryopreservation of oocytes.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Teratogenicity assessment of new antiviral drugs using 3D morphogenesis models
  • 批准号:
    10741474
  • 项目类别:
  • 资助金额:
    $15.65万
  • 财政年份:
    2023
  • 负责人:
    YUSUKE MARIKAWA
  • 依托单位:
Human pluripotent stem cell-based assessment of dolutegravir teratogenicity
  • 批准号:
    10231131
  • 项目类别:
  • 资助金额:
    $7.8万
  • 财政年份:
    2020
  • 负责人:
    YUSUKE MARIKAWA
  • 依托单位:
Human pluripotent stem cell-based assessment of dolutegravir teratogenicity
  • 批准号:
    10043778
  • 项目类别:
  • 资助金额:
    $7.78万
  • 财政年份:
    2020
  • 负责人:
    YUSUKE MARIKAWA
  • 依托单位:
Regeneration of meiotic spindle during oocyte vitrification
  • 批准号:
    8242474
  • 项目类别:
  • 资助金额:
    $7.5万
  • 财政年份:
    2012
  • 负责人:
    YUSUKE MARIKAWA
  • 依托单位:
海外基金